Regulation
FDA approves Abbott’s Libre Duo 10 Day dual glucose-ketone monitor
Abbott received FDA authorization for the Libre Duo 10 Day, a continuous glucose and ketone monitoring system. The device is designed for people with diabetes and claims to be the first to simultaneously track both glucose and ketone levels in a single wearable monitor.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network